NorthRock Partners’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$205K Buy
+515
New +$147K ﹤0.01% 641
2025
Q4
Sell
-3,635
Closed -$946K 757
2025
Q3
$946K Buy
3,635
+1,241
+52% +$326K 0.02% 360
2025
Q2
$585K Buy
2,394
+1,595
+200% +$398K 0.02% 361
2025
Q1
$212K Sell
799
-181
-18% -$49K 0.01% 552
2024
Q4
$249K Sell
980
-972
-50% -$261K 0.01% 523
2024
Q3
$620K Sell
1,952
-192
-9% -$68.3K 0.02% 315
2024
Q2
$803K Buy
2,144
+1,267
+144% +$428K 0.03% 231
2024
Q1
$305K Sell
877
-178
-17% -$67.5K 0.01% 478
2023
Q4
$484K Buy
+1,055
New +$520K 0.02% 327
2023
Q2
Sell
-428
Closed -$208K 330
2023
Q1
$208K Sell
428
-88
-17% -$43.5K 0.02% 307
2022
Q4
$264K Buy
516
+64
+14% +$33.6K 0.03% 270
2022
Q3
$219K Sell
452
-13
-3% -$6.32K 0.03% 271
2022
Q2
$218K Buy
+465
New +$207K 0.02% 280

Other funds holding HUM

NorthRock Partners's HUM Position: Q2 2026 in Review

NorthRock Partners opened a new position in Humana (HUM) in Q2 2026: 515 shares worth $205K. The stake represents ﹤0.01% of the portfolio and ranks #641 among its holdings. This is a return to the name: NorthRock Partners previously reported a position in HUM as recently as Q3 2025.

NorthRock Partners first reported a position in HUM in Q2 2022 and has held it in 13 quarters since. The position peaked at $946K in Q3 2025. 924 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • NorthRock Partners held 515 shares of Humana worth $205K as of Q2 2026.
  • Humana was a new NorthRock Partners position in Q2 2026.
  • Humana made up ﹤0.01% of NorthRock Partners's portfolio in Q2 2026, its #641 holding.
  • NorthRock Partners first reported a position in Humana in Q2 2022 and has held it in 13 quarters since.
  • NorthRock Partners's Humana position peaked at $946K in Q3 2025.
  • 924 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.